Expert Opinion on Emerging Drugs

Papers
(The H4-Index of Expert Opinion on Emerging Drugs is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Emerging drugs for hemophilia A: insights into phase II and III clinical trials67
Emerging therapeutics in Huntington’s disease24
A review of phase II and III drugs for the treatment and management of endometriosis21
Emerging immune tolerance therapies for neuromyelitis optica spectrum disorder17
Combined chemo-immunotherapy in advanced non-small cell lung cancer: feasible in the elderly?17
Emerging and traditional 5-α reductase inhibitors and androgen receptor antagonists for male androgenetic alopecia15
New drugs targeting calcitonin gene-related peptide for the management of migraines14
Emerging drugs for the treatment of acne: a review of phase 2 & 3 trials13
Emerging drugs for the treatment of postsurgical pain13
Evolving role of VIADISC for chronic low back and discogenic pain: a narrative review12
Emerging medicines to improve the basic defect in cystic fibrosis11
How can we prevent diarrhea induced by systemic treatments in oncological patients? An evaluation of phase II trials11
0.059383869171143